Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

128

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change
10/07/26	€0.1664	-0.36%
09/07/26	€0.1670	0.00%
08/07/26	€0.1670	-2.22%
07/07/26	€0.1708	+1.07%
06/07/26	€0.1690	0.00%

Delayed Quote Deutsche Boerse AG

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Closed - Deutsche Boerse AG Other stock markets 20:40:46 10/07/2026 BST			5-day change	1st Jan Change
0.1664 ^EUR	-0.36%		-1.54%	-18.63%

06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT

Market Cap	54.15M 61.91M 49.95M 46.13M 87.54M 5.9B 89.01M 597M 234M 2.91B 232M 227M 10B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	54.28M 62.05M 50.06M 46.24M 87.74M 5.92B 89.21M 598M 235M 2.92B 233M 228M 10.02B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
06-11	Klea Holding announces the launch of its new subsidiary
04-23	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-01	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
03-31	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
01-19	Klea Holding Increases Annual Revenue by 28%
01-19	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
01-19	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/10/25	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI
27/10/25	Klea Holding Buys Office Space at Skyscraper Project in Dubai	MT
18/09/25	Klea Holding SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
18/08/25	Klea Holding SA commences an Equity Buyback Plan for 30,751,431 shares, representing 10% of its issued share capital for ?46.13 million, under the authorization approved on June 10, 2025.	CI

06-11	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
04-23	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
04-23	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT
04-01	Klea Holding : Klea Holding is accelerating its diversification into the healthcare sector with the creation of Klea Pharmaceuticals	AT
01-19	Klea Holding : Klea Holding reports profitable growth of 34% in turnover in 2025 at constant exchange rates	AT

Klea Holding Share Price Deutsche Boerse AG

Stocks

7V91

FR0013481835

Healthcare Facilities & Services

Valuation: Klea Holding

Chart: Klea Holding

Latest news : Klea Holding

Analysts' recommendations: Klea Holding

Press Releases: Klea Holding

News in other languages: Klea Holding

Quotes and Performance

Course Extremes

Managers and Directors: Klea Holding

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

07-06	Klea Holding : Déclaration des transactions sur actions propres
06-29	Klea Holding : Déclaration des transactions sur actions propres
06-12	Klea Holding : Déclaration des transactions sur actions propres
06-11	Bourse : J-1 avant SpaceX, Oracle à la peine, contrat pour Airbus
06-11	Klea Holding annonce le démarrage de sa nouvelle filiale

1 day	-0.36%
1 week	-1.54%
Current month	-1.54%
1 month	-10.05%
3 months	-1.54%
6 months	-23.84%
Current year	-18.63%

1 week	0.17	0.17
1 month	0.17	0.2
Current year	0.16	0.24
1 year	0.16	0.3
3 years	0.14	0.5
5 years	0.07	0.58
10 years	0	14.84

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	21/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	31/03/2022

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	31/03/2022
Paul Amsellem BRD	Director/Board Member	51	13/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLEA HOLDING	-0.36%	-1.54%	-	-	61.91M
CVS HEALTH CORPORATION	+1.30%	-0.54%	+60.77%	+46.13%	133B
HCA HEALTHCARE, INC.	-0.59%	-0.95%	+8.12%	+37.97%	90.2B
FRESENIUS SE & CO. KGAA	+0.83%	+0.33%	+1.50%	+69.94%	27.41B
QUEST DIAGNOSTICS INCORPORATED	-0.29%	-3.84%	+23.41%	+47.87%	22.96B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.52%	-1.33%	-18.53%	-27.89%	19.9B
TENET HEALTHCARE CORPORATION	-1.22%	+0.26%	+16.22%	+147.88%	17.59B
REDE D'OR SÃO LUIZ S.A.	+2.48%	+0.76%	+8.17%	+14.97%	15.5B
DAVITA INC.	+1.45%	-0.90%	+63.31%	+125.87%	14.95B
FRESENIUS MEDICAL CARE AG	+0.22%	+2.02%	-9.36%	-4.92%	12.75B
Average	+0.43%	-0.35%	+17.07%	+50.87%	39.35B
Weighted average by Cap.	+0.53%	-0.60%	+28.96%	+47.07%

	2024	2025
Net sales	17.26M 19.73M 15.92M 14.7M 27.9M 1.88B 28.37M 190M 74.7M 927M 74.09M 72.48M 3.19B	22.17M 25.34M 20.45M 18.88M 35.83M 2.42B 36.43M 244M 95.93M 1.19B 95.15M 93.08M 4.09B
Net income	1.4M 1.61M 1.3M 1.2M 2.27M 153M 2.31M 15.48M 6.08M 75.47M 6.03M 5.9M 259M	2.28M 2.61M 2.1M 1.94M 3.69M 249M 3.75M 25.14M 9.87M 123M 9.79M 9.58M 421M
Net Debt	2.58M 2.94M 2.38M 2.19M 4.16M 281M 4.23M 28.38M 11.14M 138M 11.05M 10.81M 475M	125K 143K 115K 106K 202K 13.63M 205K 1.38M 541K 6.71M 537K 525K 23.08M